Copper-Based biomaterials for anti-tumor therapy: Recent advances and perspectives
Acta Biomaterialia · 2025-02 · 193 · 107-127
DOI: 10.1016/j.actbio.2025.01.014 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Acta Biomaterialia, 2025-02. Verfasst von Shufang Zhang und 1 weiteren Autor:innen. Beteiligte Einrichtung: The Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education of Xiangya Hospital and School of Basic Medical Science…. Hauptthemen laut MEDLINE: Copper, Biocompatible Materials, Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 57-mal zitiert (Crossref) und nennt 190 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Central South University, Science, Technology and Innovation Commission of Shenzhen Municipality.
Abstract (Originalsprache)
Copper, an essential trace element, is integral to numerous metabolic pathways across biological systems. In recent years, copper-based biomaterials have garnered significant interest due to their superior biocompatibility and multifaceted functionalities, particularly in the treatment of malignancies such as sarcomas and cancers. On the one hand, these copper-based materials serve as efficient carriers for a range of therapeutic agents, including chemotherapeutic drugs, small molecule inhibitors, and antibodies, allowing them for precise delivery and controlled release triggered by specific modifications and stimuli. On the other hand, they can induce cell death through mechanisms such as ferroptosis, cuproptosis, apoptosis, and pyroptosis, or inhibit the proliferation and invasion of cancer cells via their outstanding properties. Furthermore, advanced design approaches enable these materials to support tumor imaging and immune activation. Despite this progress, the full scope of their functional capabilities remains to be fully elucidated. This review provides an overview of the anti-tumor functions, underlying mechanisms, and design strategies of copper-based biomaterials, along with their advantages and limitations. The aim is to provide insights into the design, study, and development of novel multifunctional biomaterials, with the ultimate goal of accelerating the clinical application of copper-based nanomaterials in cancer therapy. STATEMENT OF SIGNIFICANCE: This study explores the groundbreaking potential of copper-based biomaterials in cancer therapy, uniquely combining biocompatibility with diverse therapeutic mechanisms such as targeted drug delivery and inhibition of cancer cells through specific cell death pathways. By enhancing tumor imaging and immune activation, copper-based nanomaterials have opened new avenues for cancer treatment. This review examines these multifunctional biomaterials, highlighting their advantages and current limitations while addressing gaps in existing research. The findings aim to accelerate clinical applications of these materials in the field of oncology, providing valuable insights for the design of next-generation copper-based therapies. Therefore, this work is highly relevant to researchers and practitioners focused on innovative cancer treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education of Xiangya Hospital and School of Basic Medical Science, Central South University, Changsha, Hunan 410013, China; Hunan Key L…
Förderung
- National Natural Science Foundation of China
- Central South University
- Science, Technology and Innovation Commission of Shenzhen Municipality
- Science Fund for Distinguished Young Scholars of Hunan Province
Zitieren
APA
Zhang, S., & Peng, S. (2025). Copper-Based biomaterials for anti-tumor therapy: Recent advances and perspectives. Acta Biomaterialia, 193, 107-127. https://doi.org/10.1016/j.actbio.2025.01.014
Vancouver
Zhang S, Peng S. Copper-Based biomaterials for anti-tumor therapy: Recent advances and perspectives. Acta Biomaterialia. 2025;193:107-127. doi:10.1016/j.actbio.2025.01.014
BibTeX
@article{Zhang2025,
author = {Zhang, Shufang and Peng, Shuping},
title = {Copper-Based biomaterials for anti-tumor therapy: Recent advances and perspectives},
journal = {Acta Biomaterialia},
year = {2025},
volume = {193},
pages = {107--127},
doi = {10.1016/j.actbio.2025.01.014}
}
EUVIMED